elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37951013-C8F161EC-6ACB-4C3F-A8AC-2DD0DD5634C9
Q37951013-C8F161EC-6ACB-4C3F-A8AC-2DD0DD5634C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37951013-C8F161EC-6ACB-4C3F-A8AC-2DD0DD5634C9
Exploiting nature's rich source of proteasome inhibitors as starting points in drug development.
P2860
Q37951013-C8F161EC-6ACB-4C3F-A8AC-2DD0DD5634C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37951013-C8F161EC-6ACB-4C3F-A8AC-2DD0DD5634C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bda368ff614606e81a5a7e3e16e339d06d9776da
P2860
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition